Compounded "semaglutide" products have not been reviewed by the FDA for safety, effectiveness, or quality
At TrimRx, we are proud to support your journey toward a healthier lifestyle through science-backed, personalized programs and ongoing clinical guidance
Also, dont be afraid to hit the not interested, mute, and restrict buttons on a post or account
N Engl J Med 389(6):514526 Rosenstock J, Frias J, Jastreboff AM, Du Y, Lou J, Gurbuz S et al (2023) Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
The study was registered at (NCT05446961) and was conducted in accordance with Good Clinical Practice Guidelines (GCP) and Brazilian National Health Council resolution 466/2021